Jazz Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:J7Z Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
02 Dec 24	Sell€6,186	Patricia Carr	Individual	53	€116.72
08 Nov 24	Sell€425,658	Neena Patil	Individual	3,700	€115.04
06 Sep 24	Sell€137,524	Mary Henderson	Individual	1,410	€97.53
07 Jun 24	Sell€16,412	Patricia Carr	Individual	163	€100.68
03 May 24	Sell€508,940	Neena Patil	Individual	5,000	€101.79
07 Mar 24	Sell€401,180	Patricia Carr	Individual	3,704	€110.58
01 Mar 24	Buy€1,326,248	Philip Johnson	Individual	12,000	€110.52

Insider Trading Volume

Insider Buying: J7Z insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of J7Z?
Owner Type	Number of Shares	Ownership Percentage
State or Government	55,482	0.091%
Individual Insiders	1,732,871	2.84%
Institutions	59,213,232	97.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 66.9% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.1%	The Vanguard Group, Inc.	6,107,509	€732.9m	-3.4%	0.01%
9.71%	BlackRock, Inc.	5,872,635	€704.7m	-4.44%	0.01%
4.13%	LSV Asset Management	2,493,942	€299.3m	0.54%	0.6%
3.47%	Pacer Advisors, Inc.	2,099,378	€251.9m	15.3%	0.59%
3.22%	State Street Global Advisors, Inc.	1,946,273	€233.5m	-3.52%	0.01%
3.01%	Capital Research and Management Company	1,819,147	€218.3m	-9.92%	0.01%
2.84%	Dimensional Fund Advisors LP	1,714,346	€205.7m	40.3%	0.03%
2.82%	EcoR1 Capital, LLC	1,706,469	€204.8m	68.3%	7.39%
2.5%	Columbia Management Investment Advisers, LLC	1,512,050	€181.4m	3.47%	0.04%
2.25%	JP Morgan Asset Management	1,360,057	€163.2m	0.16%	0.02%
2.16%	Polaris Capital Management, LLC	1,305,560	€156.7m	-5.08%	2.5%
1.93%	Seamus Mulligan	1,169,300	€140.3m	0%	no data
1.9%	Camber Capital Management LP	1,150,000	€138.0m	0%	6.21%
1.84%	Geode Capital Management, LLC	1,114,778	€133.8m	-0.01%	0.01%
1.82%	Franklin Resources, Inc.	1,102,223	€132.3m	3.21%	0.05%
1.74%	Citadel Advisors LLC	1,053,521	€126.4m	171%	0.14%
1.74%	Renaissance Technologies LLC	1,049,974	€126.0m	2.35%	0.19%
1.66%	Swedbank Robur Fonder AB	1,001,932	€120.2m	0%	0.08%
1.49%	Vestal Point Capital, LP	900,000	€108.0m	-40%	9.06%
1.29%	Thompson, Siegel & Walmsley LLC	781,215	€93.7m	8.27%	1.09%
1.27%	FMR LLC	768,927	€92.3m	-9.39%	0.01%
1.12%	JOHCM (USA) Inc	675,431	€81.0m	10.4%	1.27%
1.09%	Millennium Management LLC	656,721	€78.8m	44.1%	0.07%
0.92%	AQR Capital Management, LLC	553,387	€66.4m	-10.5%	0.09%
0.88%	Charles Schwab Investment Management, Inc.	531,710	€63.8m	8.71%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/02 05:55
End of Day Share Price	2025/01/02 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jazz Pharmaceuticals plc is covered by 51 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Joel Beatty	Baird
Ishan Majumdar	Baptista Research
Richard Silver	Barclays